Multiple Endocrine Neoplasia Type 1 Clinical Trials

13 clinical trials for Multiple Endocrine Neoplasia Type 1 across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Natural History Study of Parathyroid Disorders — RECRUITING
• Familial Investigations of Childhood Cancer Predisposition — RECRUITING
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford — RECRUITING
• Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients — RECRUITING · NA
• Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients — RECRUITING
• Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Institution of an Italian Multicenter Database of Patients With Multiple Endocrine Neoplasia Type 1 (MENNET1 Database) — NOT_YET_RECRUITING
• EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors — OTHER · NA
• Routine Transcervical Thymectomy in MEN-1 Patients — COMPLETED
• 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors — TERMINATED · PHASE1
• Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer — COMPLETED · PHASE2
• Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery — COMPLETED · PHASE2
• Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor — WITHDRAWN · PHASE1

Refine this search